Exome sequencing identifies GRIN2A as frequently mutated in melanoma-Reference-Cited by-同舟云学术

Exome sequencing identifies GRIN2A as frequently mutated in melanoma

Published:2011-04-15 Issue:5 Volume:43 Page:442-446
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Wei Xiaomu, ,Walia Vijay,Lin Jimmy C,Teer Jamie K,Prickett Todd D,Gartner Jared,Davis Sean,Stemke-Hale Katherine,Davies Michael A,Gershenwald Jeffrey E,Robinson William,Robinson Steven,Rosenberg Steven A,Samuels Yardena

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng.810.pdf

Reference30 articles.

1. Jemal, A., Siegel, R., Xu, J. & Ward, E. Cancer statistics, 2010. CA Cancer J. Clin. 60, 277–300 (2010).

2. Davies, H. et al. Mutations of the BRAF gene in human cancer. Nature 417, 949–954 (2002).

3. Curtin, J.A., Busam, K., Pinkel, D. & Bastian, B.C. Somatic activation of KIT in distinct subtypes of melanoma. J. Clin. Oncol. 24, 4340–4346 (2006).

4. Prickett, T.D. et al. Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4. Nat. Genet. 41, 1127–1132 (2009).

5. Pleasance, E.D. et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463, 191–196 (2010).

Cited by 420 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Late stage melanoma is hallmarked by low NLGN4X expression leading to HIF1A accumulation;British Journal of Cancer;2024-06-20

2. Integrative genomics identifies SHPRH as a tumor suppressor gene in lung adenocarcinoma that regulates DNA damage response;British Journal of Cancer;2024-06-18

3. Computationally inferred cell-type specific epigenome-wide DNA methylation analysis unveils distinct methylation patterns among immune cells for HIV infection in three cohorts;PLOS Pathogens;2024-03-11

4. GRIN2A mutation is a novel indicator of stratifying beneficiaries of immune checkpoint inhibitors in multiple cancers;Cancer Gene Therapy;2024-01-24

5. Human Metastatic Melanoma Cell Lines Panel for In Vitro and In Vivo Investigations;Journal of Molecular Pathology;2024-01-08